Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/25/2018 |
| Start Date: | May 2004 |
| End Date: | May 2004 |
A Pilot Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under
fasted conditions
fasted conditions
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical history,
or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to exemestane or any comparable or similar
product.
We found this trial at
1
site
Click here to add this to my saved trials
